| Circular RNA vaccines against SARS-CoV-2 and emerging variants L Qu, Z Yi, Y Shen, L Lin, F Chen, Y Xu, Z Wu, H Tang, X Zhang, F Tian, ... Cell 185 (10), 1728-1744. e16, 2022 | 262 | 2022 |
| Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs L Qu, Z Yi, S Zhu, C Wang, Z Cao, Z Zhou, P Yuan, Y Yu, F Tian, Z Liu, ... Nature biotechnology 37 (9), 1059-1069, 2019 | 197 | 2019 |
| Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo Z Yi, L Qu, H Tang, Z Liu, Y Liu, F Tian, C Wang, X Zhang, Z Feng, Y Yu, ... Nature Biotechnology 40 (6), 946-955, 2022 | 67 | 2022 |
| Strand-selective base editing of human mitochondrial DNA using mitoBEs Z Yi, X Zhang, W Tang, Y Yu, X Wei, X Zhang, W Wei Nature Biotechnology 42 (3), 498-509, 2024 | 19 | 2024 |
| Author Correction: Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs L Qu, Z Yi, S Zhu, C Wang, Z Cao, Z Zhou, P Yuan, Y Yu, F Tian, Z Liu, ... Nature Biotechnology 37 (11), 1380-1380, 2019 | 9 | 2019 |
| Leveraging endogenous ADAR for programmable editing on RNA L Qu, Z Yi, S Zhu, C Wang, Z Cao, Z Zhou, P Yuan, Y Yu, F Tian, Z Liu, ... BioRxiv, 605972, 2019 | 6 | 2019 |
| Gene editing technology and its research progress in China YO Chen, Y Bao, HZ Ma, ZY Yi, Z Zhou, WS Wei Yi Chuan= Hereditas 40 (10), 900-915, 2018 | 6 | 2018 |
| Utilizing AAV-mediated LEAPER 2.0 for programmable RNA editing in non-human primates and nonsense mutation correction in humanized Hurler syndrome mice Z Yi, Y Zhao, Z Yi, Y Zhang, G Tang, X Zhang, H Tang, W Zhang, Y Zhao, ... Genome Biology 24 (1), 243, 2023 | 3 | 2023 |
| Methods and compositions for editing rnas W Wei, L Qu, YI Zongyi, S Zhu, C Wang, CAO Zhongzheng, Z Zhuo, ... US Patent App. 17/284,232, 2021 | 3 | 2021 |
| Methods and compositions for editing rnas W Wei, L Qu, YI Zongyi, S Zhu, C Wang, CAO Zhongzheng, Z Zhuo, ... US Patent App. 17/226,961, 2021 | 3 | 2021 |
| Methods and compositions for editing rnas Y Pengfei, Z Yanxia, LIU Nengyin, YI Zexuan, T Gangbin, W Wei, L Qu, ... US Patent App. 17/603,918, 2022 | 2 | 2022 |
| Methods and compositions for editing RNAs Y Pengfei, Z Yanxia, LIU Nengyin, YI Zexuan, T Gangbin, W Wei, L Qu, ... US Patent 11,702,658, 2023 | 1 | 2023 |
| Targeted rna editing by leveraging endogenous adar using engineered rnas W Wei, YI Zongyi, L Qu, F Tian, C Wang, S Zhu, Z Zhuo US Patent App. 17/626,440, 2022 | 1 | 2022 |
| Targeted rna editing by leveraging endogenous adar using engineered rnas W Wei, YI Zongyi, L Qu, F Tian, C Wang, S Zhu, Z Zhuo US Patent App. 18/303,505, 2023 | | 2023 |
| Circular rna vaccines and methods of use thereof W Wei, L Qu, YI Zongyi US Patent App. 18/022,488, 2023 | | 2023 |
| Targeted RNA editing by leveraging endogenous ADAR using engineered RNAs W Wei, YI Zongyi, L Qu, F Tian, C Wang, S Zhu, Z Zhuo US Patent 11,661,596, 2023 | | 2023 |
| Methods and Compositions for Editing RNAs W Wei, QU Liang, YI Zongyi, ZHU Shiyou, W Chunhui, CAO Zhongzheng, ... | | 2020 |
| Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs L Qu, Z Yi, S Zhu, C Wang, Z Cao, Z Zhou, P Yuan, Y Yu, F Tian, Z Liu, ... Nature biotechnology 37 (9), 1059-1069, 2019 | | 2019 |
Wensheng WeiPeking UniversityVerified email at pku.edu.cn
